ZÜRICH–(BUSINESS WIRE)–Beide Schweizer Unternehmen haben eine Zusammenarbeit auf dem Gebiet der personalisierten Kontaktlinsen für die Korrektur der altersbedingten Fehlsichtigkeit (Presbyopie) vereinbart. Ziel ist es, das Design von weichen multifok…
Author: Business Wire
Study Shows Superior Success Rate for ExTra ELT Compared With Trabectome in Patients With Glaucoma Plus Cataract Surgery
LOS ANGELES & MUNICH–(BUSINESS WIRE)–Largest published ELT study to date shows superior success rate for ExTra ELT compared to Trabectome in patients with glaucoma plus cataract surgery
Aldeyra Therapeutics Announces Positive Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, announce…
Aerie Pharmaceuticals Submits Marketing Authorisation Application for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Metrion Biosciences and LifeArc Extend Ion Channel Drug Discovery Collaboration to Accelerate Neuroscience-focused Research
CAMBRIDGE, England & LONDON–(BUSINESS WIRE)–Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuros…
Vivior en SwissLens werken samen voor de ontwikkeling van gepersonaliseerde contactlenzen
ZURICH–(BUSINESS WIRE)–Beide Zwitserse bedrijven kwamen overeen samen te gaan werken op het gebied van gepersonaliseerde multifocale zachte contactlenzen voor presbyopiecorrectie. Het doel is om het ontwerp van zachte multifocale contactlenzen te opt…
Aldeyra Therapeutics to Host Conference Call and Webcast to Announce Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Tuesday, December 3, 2019, to provide top-line results from Part 1 of the adaptive Phase 3 RENEW Trial of top…
Resumen: Vivior y SwissLens establecen una colaboración para el desarrollo de lentes de contacto personalizadas
ZURICH–(BUSINESS WIRE)–Ambas compañías suizas acordaron colaborar en el campo de las lentes de contacto blandas multifocales personalizadas para la corrección de la presbicia. El objetivo es optimizar el diseño de las lentes de contacto blandas multi…
Vivior and SwissLens establish collaboration for the development of personalized contact lenses
ZURICH–(BUSINESS WIRE)–Both Swiss companies agreed to collaborate in the field of personalized multifocal soft contact lenses for presbyopia correction. The objective is to optimize the design in soft multifocal contact lenses by using the data gener…
NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova®, on Amazon.com. Avenova Direct, NovaBay’s prescript…
Positive Phase III Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum Disorder Published in the New England Journal of Medicine
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that data from SAkuraSky, a pivotal Phase III study of the investigational medicine satralizumab for the treatment of neu…
ジーエヌコーポレーション：ナノシート手法を使用した角膜細胞移植で視力を回復、日本企業がインドで特許を交付される
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — 水疱性角膜症などの角膜内皮疾患をナノ複合ゲルシートで治療するための新規細胞移植手法を日本の科学者らが開発し、日本のジーエヌコーポレーション（GNC）にインド特許が交付されました。この手法は既に日本特許として交付されており、1人の死体ドナー角膜に由来する細胞がラボ培養した角膜内皮細胞前駆細胞を使用することで、患者数人の視力を救うことに使用できるものです。 白内障手術中の不注意な外科手術などに起因する外傷による角膜内皮疾患は毎年、インド…
GN CORPORATION：採用奈米薄片技術進行的角膜細胞移植可恢復視力；日本公司在印度獲得專利
東京–(BUSINESS WIRE)–(美國商業資訊)–日本科學家開發了一種新型細胞移植方法，採用奈米複合膠片治療角膜內皮疾病，例如水疱性角膜病變，日本GN Corporation (GNC)的這種方法獲得了印度專利。該方法先前獲得日本專利，其採用大體捐贈者角膜衍生細胞，若干例患者採用實驗室培養角膜內皮前驅細胞恢復了視力。 創傷（包括白內障手術中意外的手術創傷）導致的角膜內皮疾病，印度每年約有3萬例，全球有數百萬例，此類患者須移植角膜內皮層或完整的大體捐贈者角膜，每片大體捐贈者角膜只能恢復一例…
GN CORPORATION：采用纳米薄片技术进行的角膜细胞移植可恢复视力；日本公司在印度获得专利
东京–(BUSINESS WIRE)–(美国商业资讯)–日本科学家开发了一种新型细胞移植方法，采用纳米复合胶质薄片治疗角膜内皮疾病，例如大疱性角膜病变，日本GN Corporation (GNC)的这种方法获得了印度专利。该方法早前获得日本专利，其采用遗体供者角膜衍生细胞，若干例患者采用实验室培养角膜内皮前体细胞恢复了视力。 创伤（包括白内障手术中意外的手术创伤）导致的角膜内皮疾病，印度每年约有3万例，全球有数百万例，此类患者须移植角膜内皮层或完整的遗体供者角膜，每片遗体供者角膜只能恢复一例患…
Samenvatting: GN CORPORATION: gezichtsvermogen hersteld met hoornvliesceltransplantatie met behulp van een nanoplaattechniek; Japans bedrijf patent verleend in India
TOKIO–(BUSINESS WIRE)–Een nieuwe celtransplantatiemethode voor de behandeling van cornea-endotheelziekten zoals bulleuze keratopathie met behulp van een nanocomposietgelplaat ontwikkeld door Japanse wetenschappers, kreeg het Indiase patent van GN Cor…
GN CORPORATION: Visão restaurada com transplante de células da córnea usando uma técnica com folha de nanocomposto; empresa japonesa recebe patente na Índia
TÓQUIO–(BUSINESS WIRE)–Um novo método de transplante de células para tratar doenças endoteliais da córnea, como ceratopatia bolhosa, usando uma folha de nanocomposto de gel desenvolvida por cientistas japoneses, recebeu a patente indiana da GN Corpor…
GN CORPORATION : Restauration de la vue au moyen d’une greffe de cellules cornéennes réalisée à l’aide d’une technique de nanofeuilles : la société japonaise se voit accorder un brevet en Inde
TOKYO–(BUSINESS WIRE)–GN Corporation (GNC), au Japon, s’est vue octroyer un brevet indien pour une nouvelle méthode de transplantation cellulaire destinée à traiter les maladies des cellules endothéliales de la cornée, telles que la kératopathie bull…
EnChroma Glasses Help Color Blind Students at Lakeview Public School District
BERKELEY, Calif. & COTTONWOOD, Minn.–(BUSINESS WIRE)– #colorishere–EnChroma Glasses for Color Blindness to Help Students in School District Navigate Schoolwork Challenges; Inspired by Color Blind Student and Principal
GN CORPORATION: Restauración de la vista mediante trasplante de células de la córnea utilizando una técnica de nanolámina; empresa japonesa obtiene patente en India
TOKIO–(BUSINESS WIRE)–Un método innovador de trasplante de células para tratar enfermedades del endotelio corneal, tales como la queratopatía bullosa, utilizando una lámina de gel nanocompuesto desarrollado por científicos japoneses fue patentado en …
Sight Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference
MENLO PARK, Calif.–(BUSINESS WIRE)–Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that the company’s management i…